B2DG Events - Next Month

Topic Speaker Title Company Datesort icon Location
Repositioning for Cancer Drug Discovery by Induced Synthetic Lethality: “Teaching Combinations of Old Drugs New Tricks” Vikash J. Bhagwandin, Ph.D. Founder & CEO OncoStemyx 03/06/2018 - 8:30am Sunnyvale
Wearable Devices from Idea to FDA Approval Walt Maclay President Voler Systems 03/13/2018 - 6:00pm Wilson

B2DG Events Search